Skip to main content
OpenTrials
Completed

NCT Number: NCT05350566

Combined Effect of Exercise Intensity With Nutritional Supplementation on Skeletal Muscle Function

The main objective of this study is to determine the effectiveness of a nutritional intervention (olive leaf extract) combined with a specific training session (MICT or SIT) on PDH activation (as well as other protein expressions) and exercise-induced muscle fatigue.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–40 year

Sex eligibility

Male

Study type

Interventional

Phase

Not applicable

Primary location

Bâtiment Synathlon, quartier UNIL-Centre

Lausanne, 1015, Switzerland

About this study

Sprint interval training (SIT) is a form of interval training characterised by short bursts of intense exercise interspersed with rest periods. SIT is as, or more, effective than moderate intensity continuous training (MICT) for systemic and metabolic adaptations of muscles, despite a lower workload and shorter duration. However, the mechanisms underlying the metabolic response to SIT versus MICT are poorly understood. Our recent work (Zanou et al. 2021) suggests that increased pyruvate dehydrogenase (PDH) activity may explain why a SIT session led to greater changes in proteins involved in mitochondrial respiration compared to a MICT session.

Recently, it was found that a natural and commercially available compound based on olive leaf extract could stimulate resting mitochondrial bioenergetics by activating the mitochondrial calcium uniporter (MCU), which is involved in calcium transport across the mitochondrial membrane, directly controlling PDH activity. The main objective of this study is to determine the effectiveness of an acute nutritional intervention (olive leaf extract) combined with a specific training session (MICT or SIT) on PDH activation (as well as other protein expressions) and exercise-induced muscle fatigue.

Participants will be allocated to either a SIT (6 x 30 s all out sprints) or a MICT (1h at 50% maximal aerobic power) group and asked to come to the laboratory for five visits including one familiarization session with a triangular test for maximal aerobic power determination, the first experimental session during which they will realize the exercise with the product or a placebo and a session 24h after to assess skeletal muscle adaptations. Then after a 3 week wash-out period, they report to the laboratory for the fourth and fifth session, identical to the second and third sessions but with the other intervention (product or placebo). Muscle microbiopsies will be collected from the vastus lateralis muscle before, immediately after and 24 hours after exercise (MICT or SIT), while knee extensor neuromuscular function will be assessed at the same time points using voluntary and electrically-evoked contractions.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Being male (including females would necessitate increasing the number of included participants to consider sex as a variable which would burden the project too much).
  • Being aged between 18 and 40 years
  • Being healthy (The assessment will be done through a questionnaire and an interview/examination by a medical doctor if there is any doubts)
  • Being physically active, but not involved in any structured training program
  • Having stable dietary habits

Exclusion criteria

  • Having previous medical events that would put the participant at risk during the study
  • Ingesting caffeine on the experimental days
  • Not being currently treated for blood clotting problems
  • Taking aspirin or anti-coagulant drugs in the 48 hours preceding the experimental days in which muscle samples will be collected
  • Having allergy to xylocaine
  • Having food allergy

Treatment and study plan

Olive leaf extract

Dietary Supplement

A capsule containing 250 mg of an olive leaf extract preparation will be swallowed with a glass of water before exercise.

Placebo

Dietary Supplement

A capsule containing 336 mg of cellulose microcrystalline will be swallowed with a glass of water before exercise.

Primary outcomes

  1. PDH dephosphorylation

    Time frame: before, immediately after and 24 hours after exercise completion

    protein involved in skeletal muscle metabolism

  2. expression of OXPHOS proteins

    Time frame: before, immediately after and 24 hours after exercise completion

    proteins used as markers of oxidative phosphorylation complexes

  3. expression of MCU protein

    Time frame: before, immediately after and 24 hours after exercise completion

    protein involved in the transport of Ca2+ in the mitochondria

Secondary outcomes

  1. Maximal voluntary contraction force

    Time frame: before, immediately after and 24 hours after exercise completion

    Maximal force of the knee extensor muscles

  2. Voluntary activation level

    Time frame: before, immediately after and 24 hours after exercise completion

    overall index of central fatigue induced by exercise

  3. Peak doublet evoked at 100 Hz

    Time frame: before, immediately after and 24 hours after exercise completion

    overall index of peripheral fatigue induced by exercise

  4. M-wave amplitude

    Time frame: before, immediately after and 24 hours after exercise completion

    index of neuromuscular excitability

Sponsors and collaborators

Lead sponsor

University of Lausanne

Other

Collaborators

  • Société des Produits Nestlé (SPN)

Registry information

Acronym: NUTSPORT

Important dates

Study start
2022
Primary completion
2022
Study completion
2022
First posted
Apr 28, 2022
Registry last updated
May 10, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.